(Q33500440)

English

Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940. (English)

1 reference

Europe PubMed Central

27 July 2017

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Rinehart J

1

1 reference

Europe PubMed Central

27 July 2017

Hersh E

2

1 reference

Europe PubMed Central

27 July 2017

Issell B

3

1 reference

Europe PubMed Central

27 July 2017

Triozzi P

4

1 reference

Europe PubMed Central

27 July 2017

Buhles W

5

1 reference

Europe PubMed Central

27 July 2017

Neidhart J

6

1 reference

Europe PubMed Central

27 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1997

1 reference

Europe PubMed Central

27 July 2017

Cancer Investigation

1 reference

Europe PubMed Central

27 July 2017

15

1 reference

Europe PubMed Central

27 July 2017

403-410

1 reference

Europe PubMed Central

27 July 2017

5

1 reference

Europe PubMed Central

27 July 2017

Interleukin-1: biology, pathophysiology, and clinical prospects

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

There is more than one interleukin 1.

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

The hematopoietic activities of interleukin-1.

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Interleukin-1 and hematopoiesis

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Negative regulators of haemopoiesis--current advances

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Interleukin 1 alpha stimulates hemopoiesis but not tumor cell proliferation and protects mice from lethal total body irradiation

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Preliminary report: effects of interleukin-1 on platelet counts

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Preventive effects of interleukin 1 beta for ACNU-induced myelosuppression in malignant brain tumors: the experimental and preliminary clinical studies.

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Recombinant human interleukin-1 beta analogue as a regulator of hematopoiesis in patients receiving chemotherapy for urogenital cancers

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Identifiers

10.3109/07357909709047578

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33500440&oldid=1749480843"